Three things to know about Teladoc’s fourth-quarter financial performance:
- U.S. revenue experienced a 2% increase, reaching $564.8 million. International revenue saw a 15% increase, reaching $95.8 million.
- Teladoc Health’s Integrated Care segment revenue exhibited an 8% increase, totaling $384.4 million, while its BetterHelp segment revenue remained essentially flat at $276.2 million.
- Despite increased revenue, the net loss for the fourth quarter of 2023 was $28.9 million, or $0.17 per share. The loss was a significant improvement over the $3.8 billion loss the company recorded in the fourth quarter of 2022.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
